PortfoliosLab logo

AcelRx Pharmaceuticals, Inc. (ACRX)

Equity · Currency in USD · Last updated Mar 22, 2023

Share Price Chart


Loading data...

Performance

The chart shows the growth of $10,000 invested in AcelRx Pharmaceuticals, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $76 for a total return of roughly -99.24%. All prices are adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%100.00%150.00%200.00%250.00%NovemberDecember2023FebruaryMarch
-99.24%
211.29%
ACRX (AcelRx Pharmaceuticals, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ACRX

AcelRx Pharmaceuticals, Inc.

Return

AcelRx Pharmaceuticals, Inc. had a return of -69.47% year-to-date (YTD) and -89.10% in the last 12 months. Over the past 10 years, AcelRx Pharmaceuticals, Inc. had an annualized return of -39.64%, while the S&P 500 had an annualized return of 9.77%, indicating that AcelRx Pharmaceuticals, Inc. did not perform as well as the benchmark.


PeriodReturnBenchmark
1 month-55.48%-1.87%
Year-To-Date-69.47%4.25%
6 months-86.58%2.64%
1 year-89.10%-10.31%
5 years (annualized)-56.01%7.81%
10 years (annualized)-39.64%9.77%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2023-11.50%-29.00%
2022-29.15%-36.84%-9.47%-5.44%

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current AcelRx Pharmaceuticals, Inc. Sharpe ratio is -0.78. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.90-0.80-0.70-0.60-0.50-0.40-0.30-0.20NovemberDecember2023FebruaryMarch
-0.78
-0.44
ACRX (AcelRx Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Dividend History


AcelRx Pharmaceuticals, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%NovemberDecember2023FebruaryMarch
-99.74%
-16.55%
ACRX (AcelRx Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the AcelRx Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the AcelRx Pharmaceuticals, Inc. is 99.78%, recorded on Mar 20, 2023. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.78%Jul 23, 20132431Mar 20, 2023
-60%Jun 1, 2011135Dec 30, 2011218Nov 26, 2012353
-33.63%Feb 14, 201146Apr 19, 201127May 27, 201173
-33.4%Nov 27, 20128Dec 6, 201229Jan 18, 201337
-21.97%Feb 14, 201323Mar 19, 201316Apr 11, 201339
-15.9%Jun 12, 201310Jun 25, 20135Jul 2, 201315
-10.99%May 17, 20133May 21, 20131May 22, 20134
-9.84%Jan 23, 201312Feb 7, 20134Feb 13, 201316
-9.76%Apr 24, 20136May 1, 20134May 7, 201310
-9.29%Apr 15, 20133Apr 17, 20134Apr 23, 20137

Volatility Chart

Current AcelRx Pharmaceuticals, Inc. volatility is 195.83%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%NovemberDecember2023FebruaryMarch
195.83%
22.09%
ACRX (AcelRx Pharmaceuticals, Inc.)
Benchmark (^GSPC)